As the global cannabis industry recalibrates in the wake of U.S. Schedule III rescheduling, a new international report unveiled during Cannabis Europa 2026 suggests the next major chapter of the industry may increasingly be written in Europe.
Released this week in London by the Global Cannabis Network Collective (GCNC) in partnership with Whitney Economics, What You Need to Know: EU & UK Cannabis Market Update explores the accelerating evolution of cannabis markets across Europe and the United Kingdom. The report examines medical cannabis expansion, telemedicine adoption, international trade dynamics, pharmaceutical manufacturing standards, and the regulatory frameworks shaping the region’s future.
Long described as a “sleeping giant,” Europe’s cannabis economy is now entering what many observers believe could become one of the most consequential periods in the industry’s modern history.
“Europe is taking a far more methodical and medically oriented approach to cannabis reform than many markets pursued during earlier expansion cycles,” said Beau Whitney, lead author of the report. “That slower pace may frustrate some operators, but it is also creating a level of structure, predictability, and long-term institutional credibility that is attracting increasing international attention.”
According to the findings, Europe now represents the world’s second-largest total addressable cannabis market by value, despite the region remaining fragmented across dozens of national regulatory systems. At the same time, rapid growth in telemedicine, medical access programs, and cross-border supply chains is beginning to transform the continent into a global hub for pharmaceutical cannabis infrastructure.
The report identifies Germany as the current pace-setter for European cannabis reform, while also warning that increasing imports and growing competition are beginning to compress pricing across the market. Meanwhile, the United Kingdom continues to see significant growth through private clinics and telemedicine platforms, despite ongoing challenges related to physician education, affordability, stigma, and NHS participation.
One of the report’s central themes is the growing importance of EU GMP pharmaceutical manufacturing standards, which are increasingly becoming the gateway for companies seeking long-term participation in European medical cannabis markets. Imports into Europe are now arriving from countries including Canada, Portugal, nations across Latin America and Africa, and Australia — signaling a rapidly globalizing supply ecosystem.
“Europe is no longer simply reacting to cannabis reform,” said Jillian Reddish. “The region is increasingly helping shape what the next phase of the global cannabis industry looks like, from international trade standards and medical access models to pharmaceutical manufacturing expectations and long-term market infrastructure.”
The report also highlights regional developments unfolding across Portugal, Spain, and Czech Republic, examining how cultivation, processing, telemedicine, and emerging policy reforms are contributing to Europe’s increasingly interconnected cannabis economy. Portugal, in particular, continues strengthening its role as a cultivation and export hub serving broader European demand.
At the same time, the report warns that Europe is not immune to the same market forces already impacting more mature cannabis industries globally. Pricing compression, intensified competition, supply chain maturation, and inventory growth are beginning to place pressure on operators throughout the region — especially in Germany, where wholesale and retail pricing declines are already becoming visible.
Rather than framing cannabis solely as a disruptive frontier industry, the report argues that the sector is increasingly evolving into a global commodity market shaped by logistics, trade routes, manufacturing standards, regulatory compliance, and operational efficiency. For operators, investors, and policymakers alike, long-term success may depend less on hype and more on the ability to navigate an increasingly sophisticated international marketplace.
The full report, What You Need to Know: EU & UK Cannabis Market Update, was released during Cannabis Europa 2026 in London and is now publicly available through GCNC.
Download the Report: The full report, What You Need to Know: EU & UK Cannabis Market Update, is available at this link.
